Matteo Lazzeroni

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Polycystic Ovary Syndrome

Breast Cancer Risk

Top Venues

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Debora Macis, Elena Cavadini, Elena Albertazzi, Costantino Jemos, Emanuela Omodeo Salè, Laura Cortesi, Samuele Massarut, Marcella Gulisano, Maria Grazia Daidone, Harriet Johansson, Bernardo Bonanni
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial. Cancer prevention research (Philadelphia, Pa.) 17 (6) (2024)
Massimiliano Ruscica, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Davide Serrano, Matteo Lazzeroni, Alessandra Stefania Rizzuto, Aurora Gaeta, Alberto Corsini, Marcella Gulisano, Harriet Johansson, Bernardo Bonanni
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study. Cancers 16 (7) (2024)
Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Debora Macis, Elena Cavadini, Elena Albertazzi, Costantino Jemos, Emanuela Omodeo Salè, Laura Cortesi, Samuele Massarut, Marcella Gulisano, Maria Grazia Daidone, Harriet Johansson, Bernardo Bonanni
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial. Cancer prevention research (Philadelphia, Pa.) 17 (6) (2024)
Aliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, Harriet Johansson, Stefania Zovato, Mariateresa Nardi, Matilde Pensabene, Simona Buccolo, Andrea DeCensi, Irene Maria Briata, Luigi Pistelli, Clementina Sansone, Sara Mannucci, Valentina Aristarco, Debora Macis, Matteo Lazzeroni, Gaetano Aurilio, Chiara Arianna Accornero, Sara Gandini, Bernardo Bonanni
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer. PloS one 19 (9) (2024)
Aliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, Harriet Johansson, Stefania Zovato, Mariateresa Nardi, Matilde Pensabene, Simona Buccolo, Andrea DeCensi, Irene Maria Briata, Luigi Pistelli, Clementina Sansone, Sara Mannucci, Valentina Aristarco, Debora Macis, Matteo Lazzeroni, Gaetano Aurilio, Chiara Arianna Accornero, Sara Gandini, Bernardo Bonanni
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer. PloS one 19 (9) (2024)
Massimiliano Ruscica, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Davide Serrano, Matteo Lazzeroni, Alessandra Stefania Rizzuto, Aurora Gaeta, Alberto Corsini, Marcella Gulisano, Harriet Johansson, Bernardo Bonanni
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study. Cancers 16 (7) (2024)
Debora Macis, Federica Bellerba, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Ivana Sestak, Jack Cuzick, Andrea Decensi, Bernardo Bonanni, Sara Gandini
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients 16 (13) (2024)
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Tools to Guide Radiation Oncologists in the Management of DCIS. Healthcare (Basel, Switzerland) 12 (7) (2024)
Debora Macis, Federica Bellerba, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Ivana Sestak, Jack Cuzick, Andrea Decensi, Bernardo Bonanni, Sara Gandini
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients 16 (13) (2024)
Debora Macis, Federica Bellerba, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Ivana Sestak, Jack Cuzick, Andrea Decensi, Bernardo Bonanni, Sara Gandini
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial. Nutrients 16 (13) (2024)
Massimiliano Ruscica, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Davide Serrano, Matteo Lazzeroni, Alessandra Stefania Rizzuto, Aurora Gaeta, Alberto Corsini, Marcella Gulisano, Harriet Johansson, Bernardo Bonanni
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study. Cancers 16 (7) (2024)
Aliana Guerrieri-Gonzaga, Davide Serrano, Patrizia Gnagnarella, Harriet Johansson, Stefania Zovato, Mariateresa Nardi, Matilde Pensabene, Simona Buccolo, Andrea DeCensi, Irene Maria Briata, Luigi Pistelli, Clementina Sansone, Sara Mannucci, Valentina Aristarco, Debora Macis, Matteo Lazzeroni, Gaetano Aurilio, Chiara Arianna Accornero, Sara Gandini, Bernardo Bonanni
Low dose TamOxifen and LifestylE changes for bReast cANcer prevention (TOLERANT study): Study protocol of a randomized phase II biomarker trial in women at increased risk for breast cancer. PloS one 19 (9) (2024)
Valentina Aristarco, Davide Serrano, Patrick Maisonneuve, Aliana Guerrieri-Gonzaga, Matteo Lazzeroni, Irene Feroce, Debora Macis, Elena Cavadini, Elena Albertazzi, Costantino Jemos, Emanuela Omodeo Salè, Laura Cortesi, Samuele Massarut, Marcella Gulisano, Maria Grazia Daidone, Harriet Johansson, Bernardo Bonanni
Fenretinide in young women at genetic or familial risk of breast cancer: A placebo-controlled biomarker trial. Cancer prevention research (Philadelphia, Pa.) (2024)
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Tools to Guide Radiation Oncologists in the Management of DCIS. Healthcare (Basel, Switzerland) 12 (7) (2024)
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Tools to Guide Radiation Oncologists in the Management of DCIS. Healthcare (Basel, Switzerland) 12 (7) (2024)
Eliza Del Fiol Manna, Davide Serrano, Gaetano Aurilio, Bernardo Bonanni, Matteo Lazzeroni
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer. Healthcare (Basel, Switzerland) 11 (16) (2023)
Matteo Lazzeroni, Matteo Puntoni, Aliana Guerrieri-Gonzaga, Davide Serrano, Luca Boni, Tania Buttiron Webber, Marianna Fava, Irene Maria Briata, Livia Giordano, Maria Digennaro, Laura Cortesi, Fabio Falcini, Patrizia Serra, Franca Avino, Francesco Millo, Katia Cagossi, Elisa Gallerani, Alessia De Simone, Anna Cariello, Giuseppe Aprile, Maria Renne, Bernardo Bonanni, Andrea Decensi
Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Recurrence in Breast Noninvasive Neoplasia: A 10-Year Follow-Up of TAM-01 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luca Nicosia, Anna Carla Bozzini, Silvia Penco, Chiara Trentin, Maria Pizzamiglio, Matteo Lazzeroni, Germana Lissidini, Paolo Veronesi, Gabriel Farante, Samuele Frassoni, Vincenzo Bagnardi, Cristiana Fodor, Nicola Fusco, Elham Sajjadi, Claudia Sangalli, Filippo Pesapane
A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast. Cancers 14 (2) (2022)
Elisabetta M C Rossi, Alessandra Invento, Filippo Pesapane, Eleonora Pagan, Vincenzo Bagnardi, Nicola Fusco, Konstantinos Venetis, Valeria Dominelli, Chiara Trentin, Enrico Cassano, Laura Gilardi, Manuelita Mazza, Matteo Lazzeroni, Francesca De Lorenzi, Pietro Caldarella, Alessandra De Scalzi, Antonia Girardi, Claudia Sangalli, Luca Alberti, Virgilio Sacchini, Viviana Galimberti, Paolo Veronesi
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study. The British journal of surgery (2022)
Luca Nicosia, Antuono Latronico, Francesca Addante, Rossella De Santis, Anna Carla Bozzini, Marta Montesano, Samuele Frassoni, Vincenzo Bagnardi, Giovanni Mazzarol, Oriana Pala, Matteo Lazzeroni, Germana Lissidini, Mauro Giuseppe Mastropasqua, Enrico Cassano
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? Diagnostics (Basel, Switzerland) 11 (6) (2021)
Debora Macis, Valentina Aristarco, Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Raimondi, Matteo Lazzeroni, Ivana Sestak, Jack Cuzick, Andrea DeCensi, Bernardo Bonanni, Sara Gandini
A Novel Automated Immunoassay Platform to Evaluate the Association of Adiponectin and Leptin Levels with Breast Cancer Risk. Cancers 13 (13) (2021)
Bernardo Bonanni, Davide Serrano, Patrick Maisonneuve, Matteo Lazzeroni, Powel H Brown, Aliana Guerrieri-Gonzaga, Eva Szabo
Response to Braillon. JNCI cancer spectrum 5 (1) (2021)
Matteo Lazzeroni, Federica Bellerba, Mariarosaria Calvello, Finlay Macrae, Aung Ko Win, Mark Jenkins, Davide Serrano, Monica Marabelli, Sara Cagnacci, Gianluca Tolva, Debora Macis, Sara Raimondi, Luca Mazzarella, Susanna Chiocca, Saverio Caini, Lucio Bertario, Bernardo Bonanni, Sara Gandini
A Meta-Analysis of Obesity and Risk of Colorectal Cancer in Patients with Lynch Syndrome: The Impact of Sex and Genetics. Nutrients 13 (5) (2021)
Luca Nicosia, Giuseppe di Giulio, Anna Carla Bozzini, Marianna Fanizza, Francesco Ballati, Anna Rotili, Matteo Lazzeroni, Antuono Latronico, Francesca Abbate, Giuseppe Renne, Francesca Addante, Marco Lucioni, Enrico Cassano, Mauro Giuseppe Mastropasqua
Complete Removal of the Lesion as a Guidance in the Management of Patients with Breast Ductal Carcinoma In Situ. Cancers 13 (4) (2021)
Andrea Decensi, Matteo Puntoni, Harriet Johansson, Aliana Guerrieri-Gonzaga, Silvia Caviglia, Franca Avino, Laura Cortesi, Antonio Ponti, Maria Grazia Pacquola, Fabio Falcini, Marcella Gulisano, Maria Digennaro, Anna Cariello, Katia Cagossi, Graziella Pinotti, Matteo Lazzeroni, Davide Serrano, Irene Maria Briata, Tania Buttiron Webber, Luca Boni, Bernardo Bonanni
Effect Modifiers of Low-Dose Tamoxifen in a Randomized Trial in Breast Noninvasive Disease. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)
Matteo Lazzeroni, Giovanna Petrangolini, José Antonio Legarreta Iriberri, Jaume Pascual Avellana, Digna Tost Robusté, Sara Cagnacci, Debora Macis, Valentina Aristarco, Bernardo Bonanni, Paolo Morazzoni, Harriet Johansson, Antonella Riva
Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue. Molecules (Basel, Switzerland) 25 (12) (2020)
Matteo Lazzeroni, Andrea DeCensi, Aliana Guerrieri-Gonzaga, Eleonora Pagan, Vincenzo Bagnardi, Debora Macis, Davide Serrano, Andrea Vingiani, Giuseppina Bonizzi, Massimo Barberis, Giancarlo Pruneri, Susanne Wagner, Sara Gandini, Giuseppe Viale, Bernardo Bonanni
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (6) (2020)
Harriet Johansson, Valentina Aristarco, Sara Gandini, Jennifer Gjerde, Debora Macis, Aliana Guerrieri-Gonzaga, Davide Serrano, Matteo Lazzeroni, Agnita Rajasekaran, Clark V Williard, Gunnar Mellgren, Andrea DeCensi, Bernardo Bonanni
Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer. The pharmacogenomics journal 20 (1) (2019)